Möchten Sie immer auf dem neuesten Stand bleiben?

Phesgo offers faster administration of Perjeta and Herceptin under the skin in just minutes, compared to hours with standard intravenous administration Data showed that 85% of patients preferred...

Spark Therapeutics will present data from the initial dose cohorts of its phase I/II SPK-8011 gene therapy study, showing stable and durable factor VIII expression, substantial improvement in...

ENSPRYNG is Japan’s first and only approved therapy for both adults and children with neuromyelitis optica spectrum disorder (NMOSD) ENSPRYNG is the first and only approved therapy targeting the...

New York, June 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Companion Diagnostic Market By Technology, By Products, By Indication, By End-User, By...

If approved, Xolair® (omalizumab) will provide patients who have severe chronic rhinosinusitis with nasal polyps, not adequately controlled by intranasal corticosteroids, with the first...

LAUSANNE, Switzerland, June 26, 2020 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative...

AYBINTIO®, a biosimilar candidate referencing Avastin®i (bevacizumab), is Samsung Bioepis’ second oncology biosimilar to be recommended for marketing authorization by the European Medicines...

uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivityRoche advances...

SAN JOSE, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- Tech CU (Technology Credit Union) is pleased to formally announce the appointment of Dr. Deepti Jaggi to its Board of Directors. Deepti joined...

              AFM24: Affimed successfully completed the first dose cohort of its first-in-human phase 1/2A Study; Cohort 2 is open for patient recruitment Data on Affimed’s AFM24 (EGFR/CD16A) and...